11 We conducted a systematic review to evaluate the existing evidence on the efficacy and safety of GLP-1 RAs in the treatment of HS
La semaglutida y la tirzepatida actan de forma similar
Dipeptidyl peptidase4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: a nationwide populationbased cohort study
Peripheral nerves do possess the capacity to regenerate, unlike central nervous system neurons, but the process is agonizingly slow, roughly one millimeter per day under optimal conditions, and existing medications do nothing to accelerate it
Widely used GLP-1based medications such as Ozempic and Mounjaroprimarily for Type 2 Diabetes and weight lossare now being explored for broader therapeutic applications
Rosmaninho-Salgado, J., Marques, A